Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$8.91 -0.32 (-3.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Price to Sales (2024 - 2026)

Updated

Tonix Pharmaceuticals Holding's (TNXP) Price to Sales was 7.36 for Q2 2026, down 73.3% from 27.62 a year earlier and down 33.8% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Tonix Pharmaceuticals Holding was 10.14, up 321.4% from FY2024.

  • By year, Price to Sales came in at 2.41 in FY2024 (+174.4%) and 0.88 in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly Price to Sales since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 11.13 (Q1 2026), 10.14 (Q4 2025) and 23.85 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tonix Pharmaceuticals Holding 149.62 Mn 149.62 Mn 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.36
Mar 31, 2026 11.13
Dec 31, 2025 10.14
Sep 30, 2025 23.85
Jun 30, 2025 27.62
Mar 31, 2025 12.25
Dec 31, 2024 2.41
Sep 30, 2024 0.83
Jun 30, 2024 0.23
API Access

Tonix Pharmaceuticals Holding Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=TNXP&period=max&api_key=YOUR_API_KEY